By Aditya Raghunath
Investing.com -- Dishman Carbogen Amcis Ltd (NS:DSHM) is a smallcap pharmaceutical company. Rakesh and Rekha Jhunjhunwala own 3.18% in the company as of June 30, 2021.
On July 19, another ace investor Mukul Agarwal increased his holding in the company. He now has 2.55% stake in the company, up from 1.63% at the end of March 31, 2021.
However, while Agarwal increased his stake in the company, institutional and foreign investors have reduced their stakes. Mutual funds have reduced their stake from 8.81% at the end of March 31 to 6.62% at the end of June 30. Foreign portfolio investors (FPIs) have reduced their stake from 6.38% at the end of March to 5.91% as of June 30.
Dishman reported total income of Rs 535.27 crore for the quarter ended March 31, 2021, up 12.1% from Rs 477.51 crore it reported for the December 2020 quarter, and up 0.37 % from the corresponding period in 2021. It reported a net loss of Rs 135.02 crore for the March quarter.
The stock closed July 19 at Rs 228.8, rising over 7% yesterday. Two weeks back, YES Securities had given a target of Rs 230 for Dishman. It said that any positive news could cause the stock to move up. Will Agarwal’s buy be the spark for Dishman?